子宫肌瘤治疗前后心理社会影响的系统综述
该系统综述检索了1990年1月至2020年1月的多个数据库,纳入57项研究(18项随机对照试验和39项观察性研究),分析子宫肌瘤对绝经前女性心理社会负担的影响。结果显示,子宫肌瘤诊断在基线时对社会心理功能的损害程度与心脏病、糖尿病或乳腺癌相似或更重,治疗后生活质量评分改善。
要点
- 子宫肌瘤诊断对绝经前女性构成显著心理社会压力,其残疾评分与心脏病、糖尿病或乳腺癌相似或更高。
- 子宫肌瘤与躯体疼痛、心理健康、社会功能及性生活质量满意度相关的患者报告健康残疾显著相关。
- 所有测量工具均显示治疗后生活质量评分较基线改善,提示治疗可改善躯体和情感症状。
核心结论
- 子宫肌瘤诊断在基线时是女性显著的心理社会压力源,且相对于其他疾病而言也是如此。
- 经过验证的生活质量工具表明治疗取得了治疗成功,并改善了躯体和情感症状。
研究设计与样本
- 系统综述,检索PubMed、PsycINFO、ClinicalTrials.gov、Embase和Cochrane Library从1990年1月至2020年1月的出版物。
- 纳入57项研究:18项随机对照试验和39项观察性研究。
- 由三名评审员筛选标题和摘要,获取全文进一步分析,并使用Cochrane和纽卡斯尔-渥太华量表指南评估偏倚风险。
主要发现
- 36项简短健康调查问卷和欧洲五维生活质量量表均表明,子宫肌瘤诊断的残疾评分与心脏病、糖尿病或乳腺癌诊断相似或更高(是更大的心理社会压力源)。
- 在所有测量子宫肌瘤女性这些变量的工具中,基线生活质量评分低于治疗后。
- 子宫肌瘤与躯体疼痛、心理健康、社会功能和性生活质量满意度相关的显著患者报告健康残疾相关。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Despite the high prevalence of uterine fibroids, the psychosocial impact of fibroids has not been evaluated across different quality of life indicators and compared with other chronic conditions. Here, we rigorously analyzed available evidence pertaining to the psychosocial burden of uterine fibroids in premenopausal women and compared validated quality of life and symptom scores before and after treatment. DATA SOURCES: We searched PubMed, PsycINFO, ClinicalTrials.gov, Embase, and Cochrane Library for publications from January 1990 to January 2020. STUDY ELIGIBILITY CRITERIA: We considered English-language publications that evaluated the association between uterine fibroids diagnosed by imaging studies in premenopausal women and quality of life by standardized and validated questionnaires at baseline and after treatment. We used a detailed list of terms related to quality of life, questionnaires, and uterine fibroids to conduct the search. METHODS: Three reviewers screened titles and abstracts and then obtained full-text articles for further analysis. The reviewers assessed risk of bias using established Cochrane and Newcastle-Ottawa Scale guidelines. The quality of life scores of premenopausal women with fibroids were reviewed at baseline and compared with those of published quality of life scores in other disease populations in addition to after fibroid treatment. RESULTS: A total of 57 studies were included in the review: 18 randomized controlled trials and 39 observational studies. Of note, the 36-Item Short Form Survey and European Quality of Life Five-Dimension Scale questionnaires both indicated a diagnosis of uterine fibroids to have a disability score that was similar to or exceeded (was a greater psychosocial stressor) a diagnosis of heart disease, diabetes mellitus, or breast cancer. Quality of life scores were lower at baseline than after treatment in all instruments measuring these variables in women with uterine fibroids, indicating significantly impaired psychosocial functioning. Uterine fibroids were associated with significant patient-reported health disabilities related to bodily pain, mental health, social functioning, and satisfaction with sex life. CONCLUSION: A diagnosis of uterine fibroids was a significant psychosocial stressor among women at baseline and relative to other diseases. Validated quality of life instruments indicated therapeutic success and the improvement of both physical and emotional symptoms after treatment.
引用
- Go VAA, Thomas MC, Singh B, et al. A systematic review of the psychosocial impact of fibroids before and after treatment. Am J Obstet Gynecol. 2020. PMID: 32474012. doi:10.1016/j.ajog.2020.05.044
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。